Missed the Congress ? NO Problem

Prof. Dr Antonio Facchiano

Secretary General, EUSTM

About this speaker

Dr Facchiano is Oncology Specialist at Istituto Dermopatico dell’Immacolata, IDI-IRCCS, Rome. His current fields of interest are: novel approaches to melanoma therapy and diagnosis; identification of early non-invasive melanoma markers; cytokines expression in biological fluids of human cancer patients; identification and development of novel inhibitors of angiogenesis and tumor growth, with particular reference to melanoma; molecular properties of angiogenic factors, active peptides and inhibitors of integrins, in clinically relevant conditions (neo-angiogenesis, cancer); structure-function relationships in proteins.

Talks

Immunotherapy targets in melanoma and other cancer types

06 May 2023, 08:00 AM
Prof. Dr Antonio Facchiano

Junshi Biosciences

Founded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics.

Hemosure

We at Hemosure are proud to manufacture and sell the fastest-growing Immunological Fecal Immunochemical Test (FIT) and have established its place as an industry leader.

Incyte

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Want to sponsor this event? Contact Us